Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinyao Heping, a subsidiary of the Tianjin Pharmaceutical Group (Jinyao Group), is a prominent Chinese pharmaceutical company specializing in the development and large-scale manufacturing of essential medicines. The company is particularly recognized for its extensive portfolio of corticosteroid and hormone-based therapies, as well as anti-infectives and analgesics. Operating out of Tianjin, Jinyao Heping maintains high-standard GMP manufacturing facilities that supply both domestic and international markets. Their product range includes various dosage forms such as tablets, injections, and topical ointments, focusing on therapeutic areas like dermatology, respiratory health, and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinyao Heping.